Answers are grounded in this paper and cite their sources.
After observing an increased incidence of imprecise and sometimes erroneous use of nuclear chemistry, radiochemistry, and radiopharmacy related terms and nomenclature in scientific reports, an international working group of experts was assembled to address the issue.Upon extensive consultation with peers within the field of radiochemistry and radiopharmaceutical sciences over a 3-year period and an open discussion, consensus was achieved during the International Symposium on Radiopharmaceutical Sciences earlier last year in an open forum.The resulting, harmonised nomenclature recommendations have now been published with following aims given therein 1 :• Provide a reference source for nomenclature good practice in the radiopharmaceutical sciences.• Clarify the use of terms and rules concerning exclusively radiopharmaceutical terminology, i.e. nuclear-and radiochemical terms, symbols, and expressions.• Address gaps and inconsistencies in existing radiochemistry nomenclature rules.• Provide source literature for further harmonisation beyond our immediate peer group (publishers, editors, IUPAC, pharmacopoeias, etc.).To disseminate further the consensus recommendations, a summary (see below) has been prepared for ease of reference and for open dissemination across the field.We hope that your journal will consider incorporating these guidelines as part of your journals' manuscript preparation instructions.
No takes yet. Share an insight, caveat, or question.
Coenen et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: